Literature DB >> 32914277

Glaucoma patients have an increased level of trimethylamine, a toxic product of gut bacteria, in the aqueous humor: a pilot study.

Janusz Skrzypecki1,2, J Izdebska3, A Kamińska3, J Badowska3, J Przybek-Skrzypecka3, J Bombuy3, E Samborowska4, J P Szaflik3.   

Abstract

PURPOSE: Animal studies suggest that gut bacteria metabolites are involved in regulation of intraocular pressure or development of glaucoma. However, clinical data are lacking. Here, we wanted to compare level of trimethylamine (TMA), an uremic toxin produced by gut bacteria, along with betaine and trimethylamine N-oxide (TMAO), a substrate and a product of its metabolism, in the aqueous humor and in plasma of patients with glaucoma and their controls.
METHODS: Twenty patients were selected for cataract phacoemulsification, and 20 patients selected for phacotrabeculectomy were enrolled in the study. Patients were matched with controls on systemic diseases and estimated glomerular filtration rate. Blood samples were collected in the preoperative suite, whereas aqueous humor samples were collected as the first step of both procedures. Subsequently, level of betaine, TMA and TMAO was analyzed by means of chromatography.
RESULTS: In the aqueous humor, level of TMA, but not betaine or TMAO, was significantly higher in the phacotrabeculectomy group than in the phacoemulsification group. Plasma level of betaine, TMA and TMAO was similar between groups. In both groups, level of betaine and TMA, but not TMAO, was significantly higher in plasma than in the aqueous humor.
CONCLUSION: TMA, but not TMAO or betaine level, is increased in the aqueous humor of patients with glaucoma. TMA might play a role in pathogenesis of glaucoma; however, prospective studies are needed to confirm our findings.

Entities:  

Keywords:  Betaine; Intraocular pressure; TMA; TMAO

Mesh:

Substances:

Year:  2020        PMID: 32914277      PMCID: PMC7840632          DOI: 10.1007/s10792-020-01587-y

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  30 in total

1.  Trimethylamine N-oxide promotes atherosclerosis via CD36-dependent MAPK/JNK pathway.

Authors:  Jin Geng; Chenchen Yang; Bingjian Wang; Xiwen Zhang; Tingting Hu; Yang Gu; Ju Li
Journal:  Biomed Pharmacother       Date:  2017-11-07       Impact factor: 6.529

Review 2.  Trimethylamine N-oxide: A harmful, protective or diagnostic marker in lifestyle diseases?

Authors:  Artur Nowiński; Marcin Ufnal
Journal:  Nutrition       Date:  2017-08-07       Impact factor: 4.008

Review 3.  Colonic bacterial metabolites and human health.

Authors:  Wendy R Russell; Lesley Hoyles; Harry J Flint; Marc-Emmanuel Dumas
Journal:  Curr Opin Microbiol       Date:  2013-07-20       Impact factor: 7.934

4.  Trimethylamine But Not Trimethylamine Oxide Increases With Age in Rat Plasma and Affects Smooth Muscle Cells Viability.

Authors:  Kinga Jaworska; Marek Konop; Tomasz Hutsch; Karol Perlejewski; Marek Radkowski; Marta Grochowska; Anna Bielak-Zmijewska; Grażyna Mosieniak; Ewa Sikora; Marcin Ufnal
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2020-06-18       Impact factor: 6.053

Review 5.  The role of blood pressure in glaucoma.

Authors:  Zheng He; Algis J Vingrys; James A Armitage; Bang V Bui
Journal:  Clin Exp Optom       Date:  2011-01-24       Impact factor: 2.742

6.  Role of carnitine in disease.

Authors:  Judith L Flanagan; Peter A Simmons; Joseph Vehige; Mark Dp Willcox; Qian Garrett
Journal:  Nutr Metab (Lond)       Date:  2010-04-16       Impact factor: 4.169

7.  Butyrate, a Gut Bacterial Metabolite, Lowers Intraocular Pressure in Normotensive But Not in Hypertensive Rats.

Authors:  Janusz Skrzypecki; Tymoteusz Żera; Marcin Ufnal
Journal:  J Glaucoma       Date:  2018-09       Impact factor: 2.503

8.  TMA (trimethylamine), but not its oxide TMAO (trimethylamine-oxide), exerts haemodynamic effects: implications for interpretation of cardiovascular actions of gut microbiome.

Authors:  Kinga Jaworska; Klaudia Bielinska; Marta Gawrys-Kopczynska; Marcin Ufnal
Journal:  Cardiovasc Res       Date:  2019-12-01       Impact factor: 10.787

Review 9.  High Blood Pressure and Cardiovascular Disease.

Authors:  Flávio D Fuchs; Paul K Whelton
Journal:  Hypertension       Date:  2019-12-23       Impact factor: 10.190

Review 10.  Implication of Trimethylamine N-Oxide (TMAO) in Disease: Potential Biomarker or New Therapeutic Target.

Authors:  Manuel H Janeiro; María J Ramírez; Fermin I Milagro; J Alfredo Martínez; Maite Solas
Journal:  Nutrients       Date:  2018-10-01       Impact factor: 5.717

View more
  3 in total

1.  Metabolomics in Primary Open Angle Glaucoma: A Systematic Review and Meta-Analysis.

Authors:  Yizhen Tang; Simran Shah; Kin-Sang Cho; Xinghuai Sun; Dong Feng Chen
Journal:  Front Neurosci       Date:  2022-05-12       Impact factor: 5.152

Review 2.  Mucosal immunology of the ocular surface.

Authors:  Cintia S de Paiva; Anthony J St Leger; Rachel R Caspi
Journal:  Mucosal Immunol       Date:  2022-08-24       Impact factor: 8.701

3.  Trimethylamine N-Oxide, a Gut Microbiota-Derived Metabolite, Is Associated with Cardiovascular Risk in Psoriasis: A Cross-Sectional Pilot Study.

Authors:  Mariusz Sikora; Norbert Kiss; Albert Stec; Joanna Giebultowicz; Emilia Samborowska; Radoslaw Jazwiec; Michal Dadlez; Malgorzata Olszewska; Lidia Rudnicka
Journal:  Dermatol Ther (Heidelb)       Date:  2021-05-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.